[go: up one dir, main page]

BR9808466A - Method for oral protein distribution - Google Patents

Method for oral protein distribution

Info

Publication number
BR9808466A
BR9808466A BR9808466-6A BR9808466A BR9808466A BR 9808466 A BR9808466 A BR 9808466A BR 9808466 A BR9808466 A BR 9808466A BR 9808466 A BR9808466 A BR 9808466A
Authority
BR
Brazil
Prior art keywords
protein distribution
composition
oral protein
oral
hydrogel matrix
Prior art date
Application number
BR9808466-6A
Other languages
Portuguese (pt)
Inventor
Nicholas A Peppas
Anthony M Lowman
Tsuneji Nagai
Mariko Morishita
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of BR9808466A publication Critical patent/BR9808466A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"MéTODO PARA DISTRIBUIçãO ORAL DE PROTEìNAS" A presente invenção refere-se a uma composição e método para a administração oral de componentes bioativos a vertebrados. O método compreende a etapa de administrar oralmente ao vertebrado uma composição que compreende uma matriz de hidrogel intumescível e uma composição bioativa contida dentro de matriz de hidrogel."METHOD FOR ORAL DISTRIBUTION OF PROTEINS" The present invention relates to a composition and method for the oral administration of bioactive components to vertebrates. The method comprises the step of orally administering to the vertebrate a composition comprising an intumescible hydrogel matrix and a bioactive composition contained within the hydrogel matrix.

BR9808466-6A 1997-04-02 1998-04-02 Method for oral protein distribution BR9808466A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4228097P 1997-04-02 1997-04-02
US6136797P 1997-10-08 1997-10-08
PCT/US1998/006563 WO1998043615A1 (en) 1997-04-02 1998-04-02 Method for oral delivery of proteins

Publications (1)

Publication Number Publication Date
BR9808466A true BR9808466A (en) 2001-08-07

Family

ID=26719055

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9808466-6A BR9808466A (en) 1997-04-02 1998-04-02 Method for oral protein distribution

Country Status (14)

Country Link
EP (1) EP0975328A1 (en)
JP (1) JP2002512607A (en)
KR (1) KR20010005952A (en)
CN (1) CN1259045A (en)
AU (1) AU727053B2 (en)
BR (1) BR9808466A (en)
CA (1) CA2285457A1 (en)
IL (1) IL132176A0 (en)
NO (1) NO994757L (en)
NZ (1) NZ500075A (en)
PL (1) PL335974A1 (en)
TR (1) TR199903240T2 (en)
WO (1) WO1998043615A1 (en)
YU (1) YU49699A (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
DE10040592A1 (en) * 2000-08-15 2002-03-07 Aventis Res & Tech Gmbh & Co Composition for oral administration of drugs, e.g. peptidomimetics or sparingly soluble antibiotics, containing hydrogel copolymer of unsaturated acid and polyalkylene glycol ester as resorption improver
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
GB0206048D0 (en) * 2002-03-14 2002-04-24 Croda Int Plc Use
PT1494732E (en) 2002-03-20 2008-03-20 Mannkind Corp Inhalation apparatus
MX2007001903A (en) 2004-08-20 2007-08-02 Mannkind Corp Catalysis of diketopiperazine synthesis.
KR20130066695A (en) 2004-08-23 2013-06-20 맨카인드 코포레이션 Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
US8110212B2 (en) 2005-04-07 2012-02-07 Drexel University Bioactive thermogelling polymer systems and methods of their use
ES2560240T5 (en) 2005-07-29 2022-11-08 Stichting Groningen Centre For Drug Res pH controlled pulsatile delivery system, methods for preparation and use thereof
MX2008001643A (en) * 2005-08-01 2008-04-07 Mannkind Corp Method of preserving the function of insulin-producing cells.
KR101486397B1 (en) 2005-09-14 2015-01-28 맨카인드 코포레이션 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
BRPI0707991B8 (en) 2006-02-22 2021-05-25 Mannkind Corp methods of preparing a dry powder medicine with an improved pharmaceutical property, said dry powder and using an effective amount of the dry powder
EP2389960B1 (en) 2006-06-15 2018-02-28 MicroVention, Inc. Environmentally responsive hydrogel
CN101903051B (en) 2007-12-21 2013-07-31 微温森公司 Hydrogel filaments for biomedical applications
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
RU2608439C2 (en) 2008-06-13 2017-01-18 Маннкайнд Корпорейшн Dry powder inhaler and drug delivery system
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI532497B (en) 2008-08-11 2016-05-11 曼凱公司 Ultra-fast use of insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2676695A3 (en) 2009-03-11 2017-03-01 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
US10639396B2 (en) 2015-06-11 2020-05-05 Microvention, Inc. Polymers
EP2424775B1 (en) 2009-04-30 2016-02-10 Technip France Spar mooring line sharing method and system
CN102647979B (en) 2009-06-12 2015-03-04 曼金德公司 Diketopiperazine particles with defined specific surface area
HUP0900482A2 (en) 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
KR20120090052A (en) 2009-09-24 2012-08-16 마이크로벤션, 인코포레이티드 Injectable hydrogel filaments for biomedical uses
KR101745748B1 (en) 2009-10-26 2017-06-12 마이크로벤션, 인코포레이티드 Embolization device constructed from expansile polymer
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
EP2694402B1 (en) 2011-04-01 2017-03-22 MannKind Corporation Blister package for pharmaceutical cartridges
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
WO2013063160A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
US9011884B2 (en) 2012-04-18 2015-04-21 Microvention, Inc. Embolic devices
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
EP3587404B1 (en) 2013-03-15 2022-07-13 MannKind Corporation Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
CA2918369C (en) 2013-07-18 2021-06-29 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
WO2015021044A1 (en) * 2013-08-05 2015-02-12 University Of Rochester Compositions and methods for stimuli-responsive release of a therapeutic agent
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
EP3137124B1 (en) 2014-04-29 2019-01-09 Microvention, Inc. Polymers including active agents
WO2015167751A1 (en) 2014-04-29 2015-11-05 Microvention, Inc. Polymers
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10265405B2 (en) 2014-11-18 2019-04-23 Board Of Regents, The University Of Texas System Polymers for delivery of factor VIII and/or factor IX
EP4633678A1 (en) * 2022-12-16 2025-10-22 Wake Forest University Health Sciences Hydrogel compositions and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976576A (en) * 1956-04-24 1961-03-28 Wichterle Otto Process for producing shaped articles from three-dimensional hydrophilic high polymers
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
DE1617393C2 (en) * 1966-01-06 1982-11-11 Československá akademie věd, Praha Process for the preparation of hydrophilic crosslinked copolymers containing biologically active substances
US3607848A (en) * 1967-08-07 1971-09-21 Ceskoslovenska Akademie Ved Method for preparing insoluble,cross-linked organic hydrogels comprising copolymers of glycol monoesters with diesters
US3885078A (en) * 1968-03-06 1975-05-20 Ceskoslovenska Akademie Ved Hydrogel laminates and method of manufacturing thereof
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
FR2601026B1 (en) * 1986-04-15 1988-09-16 Rhone Poulenc Chimie DRY MATERIAL MOISTURIZABLE IN AN AQUEOUS GEL CONTAINING PARTICLES OF DISPERSE POLYMERS, METHOD FOR ITS PREPARATION AND ITS APPLICATION IN BIOLOGY

Also Published As

Publication number Publication date
EP0975328A1 (en) 2000-02-02
CA2285457A1 (en) 1998-10-08
WO1998043615A1 (en) 1998-10-08
YU49699A (en) 2002-12-10
PL335974A1 (en) 2000-06-05
IL132176A0 (en) 2001-03-19
AU727053B2 (en) 2000-11-30
KR20010005952A (en) 2001-01-15
JP2002512607A (en) 2002-04-23
NZ500075A (en) 2001-03-30
NO994757D0 (en) 1999-09-30
TR199903240T2 (en) 2000-05-22
AU6880998A (en) 1998-10-22
CN1259045A (en) 2000-07-05
NO994757L (en) 1999-11-29

Similar Documents

Publication Publication Date Title
BR9808466A (en) Method for oral protein distribution
BR9807577A (en) Method to prevent and delay the onset of Alzheimer's disease and its composition
BR9611137A (en) Compositions and methods for oral distribution of pharmaceutical agents
BR9608067A (en) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
PT952829E (en) PHENOFIBRATE PHARMACEUTICAL COMPOSITION WHICH PRESENTS HIGH BIODISPONIBILITY AND ITS PREPARATION
BR9602542A (en) Compound method for the treatment of a glycogen phosphorylase-dependent disease pharmaceutical composition and process for the preparation of a compound
PT96438A (en) PROCESS FOR THE PREPARATION OF LIPIDEO-SELECTIVE ANTI-OXIDANT AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BRPI9710372B8 (en) compound, and, pharmaceutical composition.
PT835246E (en) AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
IT1255258B (en) PHARMACEUTICAL COMPOSITIONS FOR THE NASAL APPLICATION.
BR9502555A (en) Composition consisting of a dendrimer and an active substance occluded in the dendrimer process for the preparation of such a composition and process for the release of an active substance
BR0107535A (en) Use of carotenoids and unit dosage form of these
BR9909138A (en) Combination for the treatment of alcohol and drug addiction containing an opioid antagonist and a nmda receptor complex modulator
FI963679L (en) Stabilized composition for oral administration of peptides
BR9808875A (en) Combination of painkillers
BR9713215A (en) Coated particle formulation
ES2168457T3 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A DISMUTE SUPEROXIDE.
ES2181710T3 (en) ADENOVIRUS RECOMBINANTS AND ITS USE IN GENE THERAPY FOR THE TREATMENT OF EYE PATHOLOGIES.
BR9809678A (en) Triptolyte derivatives useful in the treatment of autoimmune diseases
BR9809673A (en) Triptolide derivatives useful in the treatment of autoimmune diseases
BR9507451A (en) Pharmaceutical composition use of an amount of (i) a standardized antigen together with an amount of (ii) a polypeptide and product containing an amount of (i) a standardized antigen together with an amount of (ii) a polypeptide
PT1012186E (en) USE OF KGF PROTEIN PRODUCT (S) AND GLP-2 PROTEIN PRODUCT (S) FOR THE PREPARATION OF A MEDICINAL PRODUCT
ES2096727T5 (en) COSMETIC AND PHARMACEUTICAL PRODUCTS CONTAINING EXTENSINES.
DE59611383D1 (en) PHARMACEUTICAL FORM FOR THE APPLICATION OF PHARMACEUTICAL AGENTS AND AUXILIARIES AND METHOD FOR THE PREPARATION THEREOF
HUP9900507A3 (en) Use of levobupivacaine for producing pharmaceutical composition as an anaesthetic in pregnancy

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1889 DE 20/03/2007.